# OnCo record neowise-biotechnology (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/neowise-biotechnology/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "neowise-biotechnology" ;
  schema:name "Neowise Biotechnology"@en ;
  schema:alternateName "Neowise Biotechnology (Suzhou) Co., Ltd."@en, "新景智源生物科技"@en ;
  schema:description "Neowise Biotechnology is a Suzhou company making TCR-T cell therapies, a patient's own T cells given a receptor that recognises a marker inside cancer cells, for solid tumours. Its first product targets PRAME and a second targets a KRAS mutation."@en ;
  schema:url <https://onco.cc/companies/neowise-biotechnology/>, <https://www.neowisebio.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.neowisebio.com/>, <https://clinicaltrials.gov/study/NCT07266298>, <https://clinicaltrials.gov/study/NCT07875920> ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/lung-adenocarcinoma/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/tcr-t/> ;
  onco:targets <https://onco.cc/targets/prame/>, <https://onco.cc/targets/kras/> .